category	term	number_of_genes	number_of_genes_in_background	ncbiTaxonId	inputGenes	preferredNames	p_value	fdr	description
COMPARTMENTS	GOCC:0005737	45	7871	9606	OAS3,NMI,BST2,CMPK2,ATP4A,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,CMPK2,ATP4A,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,RNF213,CIRBP,IFITM2	3e-09	6.92e-06	Cytoplasm
COMPARTMENTS	GOCC:0005622	52	11202	9606	OAS3,NMI,BST2,PPAN,CMPK2,GMPR,ATP4A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,UBA7,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,PPAN,CMPK2,GMPR,ATP4A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,UBA7,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	1.8e-08	2.08e-05	Intracellular
COMPARTMENTS	GOCC:0005829	23	2919	9606	OAS3,NMI,BST2,HERC6,DTX3L,NLRP6,STAT2,MX2,F3,ARHGAP18,IFIT1,IFIT3,PSMB9,ISG15,DDX58,SAMD9,LGALS9,IRF9,MX1,OAS1,IFI35,PARP14,RNF213	OAS3,NMI,BST2,HERC6,DTX3L,NLRP6,STAT2,MX2,F3,ARHGAP18,IFIT1,IFIT3,PSMB9,ISG15,DDX58,SAMD9,LGALS9,IRF9,MX1,OAS1,IFI35,PARP14,RNF213	2.99e-06	0.0023	Cytosol
COMPARTMENTS	GOCC:0043229	44	9242	9606	OAS3,NMI,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT3,IFIT2,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT3,IFIT2,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	3.85e-06	0.0023	Intracellular organelle
COMPARTMENTS	GOCC:0110165	54	13853	9606	OAS3,NMI,APOL2,BST2,PPAN,CMPK2,SEMA7A,ATP4A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,APOL2,BST2,PPAN,CMPK2,SEMA7A,ATP4A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	6.81e-06	0.0031	Cellular anatomical entity
COMPARTMENTS	GOCC:0043226	45	9848	9606	OAS3,NMI,APOL2,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT3,IFIT2,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	OAS3,NMI,APOL2,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,F3,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT3,IFIT2,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	8.44e-06	0.0032	Organelle
COMPARTMENTS	GOCC:0043231	38	7476	9606	OAS3,NMI,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,LIPA,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,IFIT3,IFIT2,ISG15,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,LIPA,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,IFIT3,IFIT2,ISG15,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	1.31e-05	0.0043	Intracellular membrane-bounded organelle
COMPARTMENTS	GOCC:0043227	41	8685	9606	OAS3,NMI,APOL2,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,IFIT3,IFIT2,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	OAS3,NMI,APOL2,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,IFIT3,IFIT2,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,IFI35,TAPBP,HELZ2,RNF213,CIRBP,IFITM2	2.43e-05	0.007	Membrane-bounded organelle
COMPARTMENTS	GOCC:0098844	2	5	9606	MX2,MX1	MX2,MX1	0.00017	0.0443	Postsynaptic endocytic zone membrane
Process	GO:0060337	18	67	9606	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	1.14e-29	1.47e-25	Type i interferon signaling pathway
Process	GO:0051607	21	210	9606	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1,IFITM2	1.79e-26	5.76e-23	Defense response to virus
Process	GO:0009615	22	293	9606	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,IRF9,MX1,OAS1,IFITM2	3.35e-25	8.24e-22	Response to virus
Process	GO:0045087	28	703	9606	OAS3,NMI,BST2,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	OAS3,NMI,BST2,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	3.21e-25	8.24e-22	Innate immune response
Process	GO:0006952	32	1296	9606	OAS3,NMI,APOL2,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	OAS3,NMI,APOL2,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	5e-23	9.17e-20	Defense response
Process	GO:0051707	30	1256	9606	OAS3,NMI,BST2,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	OAS3,NMI,BST2,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	5.65e-21	8.07e-18	Response to other organism
Process	GO:0006955	32	1588	9606	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,PLAUR,OAS2,SP100,PARP9,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,IFITM2	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,PLAUR,OAS2,SP100,PARP9,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,IFITM2	2.1e-20	2.25e-17	Immune response
Process	GO:0019221	23	678	9606	OAS3,NMI,BST2,SAMHD1,PML,ISG20,STAT2,MX2,F3,OAS2,SP100,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,TRIM22,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,NMI,BST2,SAMHD1,PML,ISG20,STAT2,MX2,F3,OAS2,SP100,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,TRIM22,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	6.2e-19	6.13e-16	Cytokine-mediated signaling pathway
Process	GO:0044419	31	1899	9606	OAS3,NMI,BST2,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	OAS3,NMI,BST2,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	4.53e-17	4.16e-14	Interspecies interaction between organisms
Process	GO:0002252	24	969	9606	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,PLAUR,OAS2,PARP9,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,PLAUR,OAS2,PARP9,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,IRF9,MX1,OAS1,IFITM2	9.22e-17	7.9e-14	Immune effector process
Process	GO:0002376	34	2481	9606	OAS3,NMI,BST2,SEMA7A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,PLAUR,OAS2,SP100,PARP9,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,IFITM2	OAS3,NMI,BST2,SEMA7A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,PLAUR,OAS2,SP100,PARP9,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,IFITM2	9.87e-17	7.92e-14	Immune system process
Process	GO:0009605	33	2310	9606	OAS3,NMI,BST2,CMPK2,SEMA7A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,PLAUR,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	OAS3,NMI,BST2,CMPK2,SEMA7A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,PLAUR,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,IFITM2	1.16e-16	8.78e-14	Response to external stimulus
Process	GO:0071345	24	1013	9606	OAS3,NMI,BST2,SAMHD1,PML,ISG20,STAT2,MX2,F3,OAS2,SP100,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,NMI,BST2,SAMHD1,PML,ISG20,STAT2,MX2,F3,OAS2,SP100,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	2.45e-16	1.75e-13	Cellular response to cytokine stimulus
Process	GO:0048525	12	105	9606	OAS3,BST2,PML,ISG20,OAS2,SP100,IFIT5,IFIT1,ISG15,MX1,OAS1,IFITM2	OAS3,BST2,PML,ISG20,OAS2,SP100,IFIT5,IFIT1,ISG15,MX1,OAS1,IFITM2	6.39e-16	4.32e-13	Negative regulation of viral process
Process	GO:1903900	13	153	9606	OAS3,BST2,PML,ISG20,OAS2,IFIT5,IFIT1,ISG15,TRIM22,LGALS9,MX1,OAS1,IFITM2	OAS3,BST2,PML,ISG20,OAS2,IFIT5,IFIT1,ISG15,TRIM22,LGALS9,MX1,OAS1,IFITM2	1.25e-15	8.04e-13	Regulation of viral life cycle
Process	GO:0050792	14	215	9606	OAS3,BST2,PML,ISG20,OAS2,SP100,IFIT5,IFIT1,ISG15,TRIM22,LGALS9,MX1,OAS1,IFITM2	OAS3,BST2,PML,ISG20,OAS2,SP100,IFIT5,IFIT1,ISG15,TRIM22,LGALS9,MX1,OAS1,IFITM2	2.88e-15	1.68e-12	Regulation of viral process
Process	GO:1903901	11	86	9606	OAS3,BST2,PML,ISG20,OAS2,IFIT5,IFIT1,ISG15,MX1,OAS1,IFITM2	OAS3,BST2,PML,ISG20,OAS2,IFIT5,IFIT1,ISG15,MX1,OAS1,IFITM2	3.67e-15	2.05e-12	Negative regulation of viral life cycle
Process	GO:0006950	37	3485	9606	OAS3,NMI,APOL2,BST2,GMPR,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,CIRBP,IFITM2	OAS3,NMI,APOL2,BST2,GMPR,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,PARP14,CIRBP,IFITM2	5.8e-15	3.11e-12	Response to stress
Process	GO:0045071	10	61	9606	OAS3,BST2,ISG20,OAS2,IFIT5,IFIT1,ISG15,MX1,OAS1,IFITM2	OAS3,BST2,ISG20,OAS2,IFIT5,IFIT1,ISG15,MX1,OAS1,IFITM2	7.5e-15	3.71e-12	Negative regulation of viral genome replication
Process	GO:0034341	12	182	9606	OAS3,NMI,BST2,PML,OAS2,SP100,TRIM22,LGALS9,HLA-A,IRF9,OAS1,IFITM2	OAS3,NMI,BST2,PML,OAS2,SP100,TRIM22,LGALS9,HLA-A,IRF9,OAS1,IFITM2	2.97e-13	1.41e-10	Response to interferon-gamma
Process	GO:0060333	9	70	9606	OAS3,NMI,PML,OAS2,SP100,TRIM22,HLA-A,IRF9,OAS1	OAS3,NMI,PML,OAS2,SP100,TRIM22,HLA-A,IRF9,OAS1	1.34e-12	5.92e-10	Interferon-gamma-mediated signaling pathway
Process	GO:0007166	27	2325	9606	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,F3,PLAUR,OAS2,SP100,WLS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,TRIM22,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,F3,PLAUR,OAS2,SP100,WLS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,TRIM22,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	4.31e-11	1.84e-08	Cell surface receptor signaling pathway
Process	GO:0071346	10	161	9606	OAS3,NMI,PML,OAS2,SP100,TRIM22,LGALS9,HLA-A,IRF9,OAS1	OAS3,NMI,PML,OAS2,SP100,TRIM22,LGALS9,HLA-A,IRF9,OAS1	5.88e-11	2.44e-08	Cellular response to interferon-gamma
Process	GO:0071310	27	2369	9606	OAS3,NMI,BST2,CMPK2,SAMHD1,PML,ISG20,STAT2,MX2,F3,OAS2,SP100,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,NMI,BST2,CMPK2,SAMHD1,PML,ISG20,STAT2,MX2,F3,OAS2,SP100,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	6.62e-11	2.66e-08	Cellular response to organic substance
Process	GO:0035455	6	23	9606	BST2,MX2,IFIT3,IFIT2,OAS1,IFITM2	BST2,MX2,IFIT3,IFIT2,OAS1,IFITM2	2.07e-10	8.05e-08	Response to interferon-alpha
Process	GO:0002831	11	406	9606	NMI,SAMHD1,PML,DTX3L,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	NMI,SAMHD1,PML,DTX3L,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	2.68e-08	9.58e-06	Regulation of response to biotic stimulus
Process	GO:0050896	44	8046	9606	OAS3,NMI,APOL2,BST2,CMPK2,GMPR,SEMA7A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,PARP9,ARHGAP18,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,CIRBP,IFITM2	OAS3,NMI,APOL2,BST2,CMPK2,GMPR,SEMA7A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,PARP9,ARHGAP18,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,PARP14,CIRBP,IFITM2	3.41e-08	1.19e-05	Response to stimulus
Process	GO:0031347	13	674	9606	NMI,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	NMI,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	6.27e-08	2.12e-05	Regulation of defense response
Process	GO:0007165	33	4876	9606	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,PLAUR,OAS2,SP100,WLS,ARHGAP18,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,PLAUR,OAS2,SP100,WLS,ARHGAP18,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	1.29e-07	4.25e-05	Signal transduction
Process	GO:0032101	15	1013	9606	NMI,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,F3,PLAUR,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	NMI,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,F3,PLAUR,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	1.54e-07	4.95e-05	Regulation of response to external stimulus
Process	GO:0050777	7	154	9606	NMI,BST2,SAMHD1,NLRP6,LGALS9,HLA-A,PARP14	NMI,BST2,SAMHD1,NLRP6,LGALS9,HLA-A,PARP14	4.11e-07	0.00013	Negative regulation of immune response
Process	GO:0042221	30	4333	9606	OAS3,NMI,BST2,CMPK2,SEMA7A,SAMHD1,PML,ISG20,STAT2,MX2,F3,PLAUR,OAS2,SP100,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,NMI,BST2,CMPK2,SEMA7A,SAMHD1,PML,ISG20,STAT2,MX2,F3,PLAUR,OAS2,SP100,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	5.15e-07	0.00016	Response to chemical
Process	GO:0045824	5	61	9606	NMI,SAMHD1,LGALS9,HLA-A,PARP14	NMI,SAMHD1,LGALS9,HLA-A,PARP14	1.35e-06	0.00039	Negative regulation of innate immune response
Process	GO:0048519	33	5389	9606	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,LGALS9B,UBA7,PLAUR,OAS2,SP100,ZC3HC1,EDC4,PARP9,IFIT5,IFIT1,IFIT3,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,MX1,OAS1,HELZ2,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,LGALS9B,UBA7,PLAUR,OAS2,SP100,ZC3HC1,EDC4,PARP9,IFIT5,IFIT1,IFIT3,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,MX1,OAS1,HELZ2,PARP14,RNF213,CIRBP,IFITM2	1.54e-06	0.00043	Negative regulation of biological process
Process	GO:0001818	8	280	9606	NMI,BST2,PML,LGALS9B,UBA7,ISG15,DDX58,LGALS9	NMI,BST2,PML,LGALS9B,UBA7,ISG15,DDX58,LGALS9	1.73e-06	0.00047	Negative regulation of cytokine production
Process	GO:0002230	4	32	9606	PML,DTX3L,PARP9,DDX58	PML,DTX3L,PARP9,DDX58	3.52e-06	0.00094	Positive regulation of defense response to virus by host
Process	GO:0002697	9	418	9606	BST2,SEMA7A,PML,DTX3L,PARP9,IFIT1,DDX58,LGALS9,HLA-A	BST2,SEMA7A,PML,DTX3L,PARP9,IFIT1,DDX58,LGALS9,HLA-A	3.59e-06	0.00094	Regulation of immune effector process
Process	GO:0002682	16	1514	9606	NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,LGALS9B,PARP9,IFIT1,PSMB9,ISG15,DDX58,LGALS9,HLA-A,PARP14	NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,LGALS9B,PARP9,IFIT1,PSMB9,ISG15,DDX58,LGALS9,HLA-A,PARP14	4.63e-06	0.0012	Regulation of immune system process
Process	GO:0050688	5	81	9606	PML,DTX3L,PARP9,IFIT1,DDX58	PML,DTX3L,PARP9,IFIT1,DDX58	5.03e-06	0.0013	Regulation of defense response to virus
Process	GO:0060700	3	9	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	5.02e-06	0.0013	Regulation of ribonuclease activity
Process	GO:0032102	8	367	9606	NMI,SEMA7A,SAMHD1,NLRP6,PLAUR,LGALS9,HLA-A,PARP14	NMI,SEMA7A,SAMHD1,NLRP6,PLAUR,LGALS9,HLA-A,PARP14	1.2e-05	0.0027	Negative regulation of response to external stimulus
Process	GO:0032480	4	45	9606	NMI,UBA7,ISG15,DDX58	NMI,UBA7,ISG15,DDX58	1.23e-05	0.0027	Negative regulation of type i interferon production
Process	GO:0035457	3	13	9606	IFIT3,IFIT2,OAS1	IFIT3,IFIT2,OAS1	1.27e-05	0.0027	Cellular response to interferon-alpha
Process	GO:0044265	12	917	9606	PML,DTX3L,ISG20,UBA7,OAS2,EDC4,CTSS,PSMB9,ISG15,USP41,HELZ2,RNF213	PML,DTX3L,ISG20,UBA7,OAS2,EDC4,CTSS,PSMB9,ISG15,USP41,HELZ2,RNF213	1.16e-05	0.0027	Cellular macromolecule catabolic process
Process	GO:0051716	35	6489	9606	OAS3,NMI,BST2,CMPK2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,PLAUR,OAS2,SP100,WLS,PARP9,ARHGAP18,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,NMI,BST2,CMPK2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,F3,PLAUR,OAS2,SP100,WLS,PARP9,ARHGAP18,CTSS,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	1.21e-05	0.0027	Cellular response to stimulus
Process	GO:0080134	15	1437	9606	NMI,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,F3,PLAUR,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	NMI,SEMA7A,SAMHD1,PML,DTX3L,NLRP6,F3,PLAUR,PARP9,IFIT1,PSMB9,DDX58,LGALS9,HLA-A,PARP14	1.15e-05	0.0027	Regulation of response to stress
Process	GO:0016032	11	776	9606	SAMHD1,PML,DTX3L,STAT2,SP100,IFIT1,PSMB9,ISG15,DDX58,TRIM22,HLA-A	SAMHD1,PML,DTX3L,STAT2,SP100,IFIT1,PSMB9,ISG15,DDX58,TRIM22,HLA-A	1.37e-05	0.0029	Viral process
Process	GO:0045088	7	301	9606	NMI,SAMHD1,PARP9,PSMB9,LGALS9,HLA-A,PARP14	NMI,SAMHD1,PARP9,PSMB9,LGALS9,HLA-A,PARP14	2.96e-05	0.0061	Regulation of innate immune response
Process	GO:0044260	29	4976	9606	NMI,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,MX2,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,USP41,HELZ2,PARP14,RNF213	NMI,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,MX2,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,USP41,HELZ2,PARP14,RNF213	3.46e-05	0.007	Cellular macromolecule metabolic process
Process	GO:0071704	38	7755	9606	OAS3,NMI,APOL2,CMPK2,GMPR,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,MX2,F3,LIPA,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,TAPBP,USP41,HELZ2,PARP14,RNF213	OAS3,NMI,APOL2,CMPK2,GMPR,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,MX2,F3,LIPA,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,TAPBP,USP41,HELZ2,PARP14,RNF213	3.46e-05	0.007	Organic substance metabolic process
Process	GO:0031348	6	212	9606	NMI,SAMHD1,NLRP6,LGALS9,HLA-A,PARP14	NMI,SAMHD1,NLRP6,LGALS9,HLA-A,PARP14	3.97e-05	0.0077	Negative regulation of defense response
Process	GO:0006807	35	6852	9606	OAS3,NMI,APOL2,CMPK2,GMPR,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,F3,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,OAS1,TAPBP,USP41,HELZ2,PARP14,RNF213	OAS3,NMI,APOL2,CMPK2,GMPR,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,F3,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,OAS1,TAPBP,USP41,HELZ2,PARP14,RNF213	4.5e-05	0.0086	Nitrogen compound metabolic process
Process	GO:0002683	8	450	9606	NMI,BST2,SAMHD1,NLRP6,LGALS9B,LGALS9,HLA-A,PARP14	NMI,BST2,SAMHD1,NLRP6,LGALS9B,LGALS9,HLA-A,PARP14	5.02e-05	0.0094	Negative regulation of immune system process
Process	GO:0050776	11	896	9606	NMI,BST2,SEMA7A,SAMHD1,NLRP6,PARP9,PSMB9,DDX58,LGALS9,HLA-A,PARP14	NMI,BST2,SEMA7A,SAMHD1,NLRP6,PARP9,PSMB9,DDX58,LGALS9,HLA-A,PARP14	5.07e-05	0.0094	Regulation of immune response
Process	GO:0001817	10	742	9606	NMI,BST2,SEMA7A,PML,LGALS9B,UBA7,ISG15,DDX58,LGALS9,HLA-A	NMI,BST2,SEMA7A,PML,LGALS9B,UBA7,ISG15,DDX58,LGALS9,HLA-A	5.43e-05	0.0097	Regulation of cytokine production
Process	GO:0043170	32	6137	9606	NMI,APOL2,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,MX2,F3,LIPA,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,USP41,HELZ2,PARP14,RNF213	NMI,APOL2,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,MX2,F3,LIPA,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,USP41,HELZ2,PARP14,RNF213	9.67e-05	0.017	Macromolecule metabolic process
Process	GO:0043122	6	251	9606	BST2,NLRP6,WLS,IFIT5,TRIM22,LGALS9	BST2,NLRP6,WLS,IFIT5,TRIM22,LGALS9	9.87e-05	0.0171	Regulation of i-kappab kinase/nf-kappab signaling
Process	GO:1901575	15	1750	9606	SAMHD1,PML,DTX3L,ISG20,UBA7,LIPA,OAS2,EDC4,CTSS,PSMB9,ISG15,TYMP,USP41,HELZ2,RNF213	SAMHD1,PML,DTX3L,ISG20,UBA7,LIPA,OAS2,EDC4,CTSS,PSMB9,ISG15,TYMP,USP41,HELZ2,RNF213	0.00011	0.0191	Organic substance catabolic process
Process	GO:0050789	47	11475	9606	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,GOLM1,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,SEMA7A,SAMHD1,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,GOLM1,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	0.00012	0.0195	Regulation of biological process
Process	GO:0046640	3	32	9606	LGALS9B,LGALS9,HLA-A	LGALS9B,LGALS9,HLA-A	0.00014	0.0238	Regulation of alpha-beta t cell proliferation
Process	GO:0002718	4	89	9606	BST2,SEMA7A,DDX58,HLA-A	BST2,SEMA7A,DDX58,HLA-A	0.00015	0.0254	Regulation of cytokine production involved in immune response
Process	GO:0070647	11	1021	9606	HERC6,PML,DTX3L,UBA7,ZC3HC1,PSMB9,DDX58,TRIM22,HLA-A,USP41,RNF213	HERC6,PML,DTX3L,UBA7,ZC3HC1,PSMB9,DDX58,TRIM22,HLA-A,USP41,RNF213	0.00016	0.0261	Protein modification by small protein conjugation or removal
Process	GO:0046596	3	35	9606	TRIM22,LGALS9,IFITM2	TRIM22,LGALS9,IFITM2	0.00018	0.0293	Regulation of viral entry into host cell
Process	GO:0044238	35	7332	9606	OAS3,NMI,APOL2,CMPK2,GMPR,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,F3,LIPA,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,OAS1,USP41,HELZ2,PARP14,RNF213	OAS3,NMI,APOL2,CMPK2,GMPR,SAMHD1,HERC6,PML,DTX3L,ISG20,UBA7,F3,LIPA,OAS2,SP100,ZC3HC1,EDC4,PARP9,CTSS,PMPCA,PSMB9,ISG15,DDX58,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,OAS1,USP41,HELZ2,PARP14,RNF213	0.00022	0.0339	Primary metabolic process
Process	GO:0032020	2	6	9606	UBA7,ISG15	UBA7,ISG15	0.00023	0.0355	ISG15-protein conjugation
Process	GO:0016567	9	729	9606	HERC6,PML,DTX3L,UBA7,ZC3HC1,PSMB9,TRIM22,HLA-A,RNF213	HERC6,PML,DTX3L,UBA7,ZC3HC1,PSMB9,TRIM22,HLA-A,RNF213	0.00026	0.0391	Protein ubiquitination
Process	GO:0065007	48	12171	9606	OAS3,NMI,BST2,SEMA7A,ATP4A,SAMHD1,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,GOLM1,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,SEMA7A,ATP4A,SAMHD1,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,GOLM1,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	0.00026	0.0391	Biological regulation
Process	GO:0043123	5	194	9606	BST2,WLS,IFIT5,TRIM22,LGALS9	BST2,WLS,IFIT5,TRIM22,LGALS9	0.00028	0.0416	Positive regulation of i-kappab kinase/nf-kappab signaling
Process	GO:0009987	54	15024	9606	OAS3,NMI,BST2,PPAN,CMPK2,GMPR,SEMA7A,ATP4A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,HELZ2,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,BST2,PPAN,CMPK2,GMPR,SEMA7A,ATP4A,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,HELZ2,PARP14,RNF213,CIRBP,IFITM2	0.00029	0.0422	Cellular process
Process	GO:0016185	2	7	9606	MX2,MX1	MX2,MX1	0.00029	0.0429	Synaptic vesicle budding from presynaptic endocytic zone membrane
Process	GO:0032649	4	106	9606	LGALS9B,ISG15,LGALS9,HLA-A	LGALS9B,ISG15,LGALS9,HLA-A	0.00029	0.0429	Regulation of interferon-gamma production
Process	GO:0051603	8	600	9606	PML,DTX3L,UBA7,CTSS,PSMB9,ISG15,USP41,RNF213	PML,DTX3L,UBA7,CTSS,PSMB9,ISG15,USP41,RNF213	0.00035	0.0496	Proteolysis involved in cellular protein catabolic process
Component	GO:0005829	35	5193	9606	OAS3,NMI,BST2,GMPR,HERC6,PML,DTX3L,NLRP6,LGALS9B,STAT2,UBA7,MX2,OAS2,WLS,EDC4,PARP9,ARHGAP18,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,LGALS9,TYMP,IRF9,MX1,OAS1,IFI35,USP41,PARP14,RNF213	OAS3,NMI,BST2,GMPR,HERC6,PML,DTX3L,NLRP6,LGALS9B,STAT2,UBA7,MX2,OAS2,WLS,EDC4,PARP9,ARHGAP18,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,LGALS9,TYMP,IRF9,MX1,OAS1,IFI35,USP41,PARP14,RNF213	3.65e-08	6.2e-05	Cytosol
Component	GO:0005737	49	11428	9606	OAS3,NMI,BST2,CMPK2,GMPR,HERC6,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,HELZ2,PARP14,RNF213,CIRBP	OAS3,NMI,BST2,CMPK2,GMPR,HERC6,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,HELZ2,PARP14,RNF213,CIRBP	6.99e-06	0.0059	Cytoplasm
Component	GO:0043231	46	10761	9606	OAS3,NMI,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT3,IFIT2,PSMB9,ISG15,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,HELZ2,PARP14,RNF213,CIRBP	OAS3,NMI,BST2,PPAN,CMPK2,SAMHD1,HERC6,PML,DTX3L,ISG20,NLRP6,LGALS9B,STAT2,UBA7,MX2,LIPA,PLAUR,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT3,IFIT2,PSMB9,ISG15,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,HELZ2,PARP14,RNF213,CIRBP	4.54e-05	0.0257	Intracellular membrane-bounded organelle
Function	GO:0001730	3	3	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	4.62e-07	0.0015	2-5-oligoadenylate synthetase activity
TISSUES	BTO:0000570	21	2543	9606	OAS3,BST2,SEMA7A,SAMHD1,HERC6,UBA7,LIPA,PLAUR,TRPV2,OAS2,EDC4,PMPCA,IFIT5,LGALS9,HLA-A,OAS1,IFI35,TAPBP,HELZ2,RNF213,CIRBP	OAS3,BST2,SEMA7A,SAMHD1,HERC6,UBA7,LIPA,PLAUR,TRPV2,OAS2,EDC4,PMPCA,IFIT5,LGALS9,HLA-A,OAS1,IFI35,TAPBP,HELZ2,RNF213,CIRBP	4.8e-06	0.0091	Hematopoietic system
TISSUES	BTO:0001489	51	12619	9606	OAS3,NMI,APOL2,BST2,CMPK2,GMPR,SEMA7A,ATP4A,SAMHD1,HERC6,PML,DTX3L,LGALS9B,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	OAS3,NMI,APOL2,BST2,CMPK2,GMPR,SEMA7A,ATP4A,SAMHD1,HERC6,PML,DTX3L,LGALS9B,STAT2,UBA7,MX2,F3,LIPA,PLAUR,TRPV2,OAS2,SP100,WLS,ZC3HC1,EDC4,PARP9,ARHGAP18,CTSS,PMPCA,IFIT5,IFIT1,IFIT3,ISG15,DDX58,SAMD9,TRIM22,GOLM1,STT3A,LGALS9,TYMP,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,HELZ2,PARP14,RNF213,CIRBP,IFITM2	1.8e-05	0.0171	Whole body
TISSUES	BTO:0000634	17	1970	9606	APOL2,CMPK2,ATP4A,HERC6,F3,PLAUR,TRPV2,WLS,EDC4,IFIT1,DDX58,SAMD9,LGALS9,HLA-A,IFI35,TAPBP,RNF213	APOL2,CMPK2,ATP4A,HERC6,F3,PLAUR,TRPV2,WLS,EDC4,IFIT1,DDX58,SAMD9,LGALS9,HLA-A,IFI35,TAPBP,RNF213	3.09e-05	0.0196	Integument
DISEASES	DOID:0060861	5	8	9606	OAS3,OAS2,DDX58,MX1,OAS1	OAS3,OAS2,DDX58,MX1,OAS1	2.18e-10	9.54e-07	Microphthalmia with limb anomalies
Keyword	KW-0051	21	127	9606	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,STAT2,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1,IFITM2	1.04e-30	7.03e-28	Antiviral defense
Keyword	KW-0399	21	324	9606	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,NLRP6,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,HLA-A,MX1,OAS1,PARP14,IFITM2	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,NLRP6,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,HLA-A,MX1,OAS1,PARP14,IFITM2	9.14e-23	3.09e-20	Innate immunity
Keyword	KW-0391	23	522	9606	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,NLRP6,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,LGALS9,HLA-A,MX1,OAS1,PARP14,IFITM2	OAS3,BST2,SAMHD1,PML,DTX3L,ISG20,NLRP6,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,LGALS9,HLA-A,MX1,OAS1,PARP14,IFITM2	2.23e-21	5.02e-19	Immunity
Keyword	KW-0945	11	534	9606	SAMHD1,PML,DTX3L,STAT2,SP100,IFIT1,PSMB9,ISG15,DDX58,TRIM22,HLA-A	SAMHD1,PML,DTX3L,STAT2,SP100,IFIT1,PSMB9,ISG15,DDX58,TRIM22,HLA-A	3.98e-07	6.72e-05	Host-virus interaction
Keyword	KW-0963	32	5028	9606	OAS3,NMI,APOL2,BST2,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,TRPV2,OAS2,SP100,EDC4,PARP9,ARHGAP18,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,LGALS9,IRF9,MX1,OAS1,PARP14,RNF213,CIRBP	OAS3,NMI,APOL2,BST2,HERC6,PML,DTX3L,ISG20,NLRP6,STAT2,MX2,TRPV2,OAS2,SP100,EDC4,PARP9,ARHGAP18,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,SAMD9,TRIM22,LGALS9,IRF9,MX1,OAS1,PARP14,RNF213,CIRBP	1.09e-06	0.00015	Cytoplasm
Keyword	KW-0694	9	670	9606	OAS3,ISG20,OAS2,IFIT5,IFIT1,IFIT2,DDX58,OAS1,CIRBP	OAS3,ISG20,OAS2,IFIT5,IFIT1,IFIT2,DDX58,OAS1,CIRBP	0.00014	0.0155	RNA-binding
KEGG	hsa05160	9	156	9606	OAS3,STAT2,MX2,OAS2,IFIT1,DDX58,IRF9,MX1,OAS1	OAS3,STAT2,MX2,OAS2,IFIT1,DDX58,IRF9,MX1,OAS1	1.07e-09	3.61e-07	Hepatitis C
KEGG	hsa05164	9	165	9606	OAS3,PML,STAT2,MX2,OAS2,DDX58,IRF9,MX1,OAS1	OAS3,PML,STAT2,MX2,OAS2,DDX58,IRF9,MX1,OAS1	1.72e-09	3.61e-07	Influenza A
KEGG	hsa05169	9	193	9606	OAS3,STAT2,OAS2,ISG15,DDX58,HLA-A,IRF9,OAS1,TAPBP	OAS3,STAT2,OAS2,ISG15,DDX58,HLA-A,IRF9,OAS1,TAPBP	6.37e-09	7.14e-07	Epstein-Barr virus infection
KEGG	hsa05162	8	138	9606	OAS3,STAT2,MX2,OAS2,DDX58,IRF9,MX1,OAS1	OAS3,STAT2,MX2,OAS2,DDX58,IRF9,MX1,OAS1	9.4e-09	7.9e-07	Measles
KEGG	hsa05168	11	479	9606	OAS3,BST2,PML,STAT2,OAS2,SP100,DDX58,HLA-A,IRF9,OAS1,TAPBP	OAS3,BST2,PML,STAT2,OAS2,SP100,DDX58,HLA-A,IRF9,OAS1,TAPBP	1.38e-07	9.25e-06	Herpes simplex virus 1 infection
KEGG	hsa04621	7	174	9606	OAS3,NLRP6,STAT2,TRPV2,OAS2,IRF9,OAS1	OAS3,NLRP6,STAT2,TRPV2,OAS2,IRF9,OAS1	9.06e-07	5.07e-05	NOD-like receptor signaling pathway
KEGG	hsa05165	6	325	9606	STAT2,MX2,ISG15,HLA-A,IRF9,MX1	STAT2,MX2,ISG15,HLA-A,IRF9,MX1	0.00039	0.0186	Human papillomavirus infection
KEGG	hsa04612	3	63	9606	CTSS,HLA-A,TAPBP	CTSS,HLA-A,TAPBP	0.00093	0.0392	Antigen processing and presentation
InterPro	IPR002934	3	7	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	2.75e-06	0.0055	Polymerase, nucleotidyl transferase domain
InterPro	IPR006116	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	8.07e-07	0.0055	2-5OAS/ClassI-CCAase, nucleotidyltransferase domain
InterPro	IPR006117	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	8.07e-07	0.0055	2-5-oligoadenylate synthetase, C-terminal  conserved site
InterPro	IPR018952	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	8.07e-07	0.0055	2-5-oligoadenylate synthetase 1, domain 2/C-terminal
InterPro	IPR026774	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	8.07e-07	0.0055	2-5-oligoadenylate synthase
InterPro	IPR043518	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	8.07e-07	0.0055	2-5-oligoadenylate synthetase, N-terminal conserved site
InterPro	IPR009909	2	2	9606	NMI,IFI35	NMI,IFI35	4.96e-05	0.0479	Nmi/IFP 35 domain
InterPro	IPR009938	2	2	9606	NMI,IFI35	NMI,IFI35	4.96e-05	0.0479	Nmi/IFP 35 domain, N-terminal
InterPro	IPR043519	3	23	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	5.76e-05	0.0479	Nucleotidyltransferase superfamily
Pfam	PF10421	3	4	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	8.07e-07	0.0028	2-5-oligoadenylate synthetase 1, domain 2, C-terminus 
Pfam	PF01909	3	11	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	8.27e-06	0.0142	Nucleotidyltransferase domain
PMID	PMID:34771433	22	38	9606	OAS3,APOL2,BST2,SAMHD1,HERC6,DTX3L,STAT2,MX2,OAS2,PARP9,CTSS,IFIT1,IFIT3,IFIT2,ISG15,DDX58,LGALS9,IRF9,MX1,OAS1,PARP14,RNF213	OAS3,APOL2,BST2,SAMHD1,HERC6,DTX3L,STAT2,MX2,OAS2,PARP9,CTSS,IFIT1,IFIT3,IFIT2,ISG15,DDX58,LGALS9,IRF9,MX1,OAS1,PARP14,RNF213	1.91e-42	7.53e-36	(2021) Multi-Omics Analysis of Glioblastoma Cells Sensitivity to Oncolytic Viruses.
PMID	PMID:31665046	20	76	9606	OAS3,CMPK2,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,TRIM22,LGALS9,MX1,OAS1,IFI35,HELZ2	OAS3,CMPK2,STAT2,MX2,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,TRIM22,LGALS9,MX1,OAS1,IFI35,HELZ2	7.82e-33	1.54e-26	(2019) Identifying novel biomarkers of the pediatric influenza infection by weighted co-expression network analysis.
PMID	PMID:33968942	18	64	9606	OAS3,BST2,SAMHD1,PML,ISG20,UBA7,MX2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,IRF9,MX1,IFITM2	OAS3,BST2,SAMHD1,PML,ISG20,UBA7,MX2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,IRF9,MX1,IFITM2	5.58e-30	7.34e-24	(2021) Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense.
PMID	PMID:31465999	17	57	9606	OAS3,BST2,SAMHD1,HERC6,STAT2,MX2,IFIT1,IFIT3,ISG15,DDX58,SAMD9,TRIM22,IRF9,MX1,OAS1,RNF213,IFITM2	OAS3,BST2,SAMHD1,HERC6,STAT2,MX2,IFIT1,IFIT3,ISG15,DDX58,SAMD9,TRIM22,IRF9,MX1,OAS1,RNF213,IFITM2	1.08e-28	1.07e-22	(2019) Virus- and Interferon Alpha-Induced Transcriptomes of Cells from the Microbat Myotis daubentonii.
PMID	PMID:34372578	19	120	9606	OAS3,BST2,SAMHD1,PML,ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,HELZ2,IFITM2	OAS3,BST2,SAMHD1,PML,ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,HELZ2,IFITM2	2.03e-27	1.6e-21	(2021) Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.
PMID	PMID:31937643	15	35	9606	OAS3,BST2,CMPK2,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT1,ISG15,DDX58,MX1,OAS1,IFI35,RNF213	OAS3,BST2,CMPK2,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT1,ISG15,DDX58,MX1,OAS1,IFI35,RNF213	2.47e-27	1.62e-21	(2020) Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection.
PMID	PMID:34490145	16	52	9606	OAS3,BST2,ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFI35	OAS3,BST2,ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFI35	3.34e-27	1.89e-21	(2021) Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated With Type I Interferon Signaling.
PMID	PMID:29215570	16	53	9606	OAS3,BST2,ISG20,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1,IFITM2	OAS3,BST2,ISG20,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1,IFITM2	4.35e-27	2.14e-21	(2017) Host Cell Restriction Factors that Limit Influenza A Infection.
PMID	PMID:24713352	15	42	9606	OAS3,BST2,SAMHD1,PML,UBA7,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS3,BST2,SAMHD1,PML,UBA7,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	2.39e-26	1.05e-20	(2014) Interferon-stimulated genes: roles in viral pathogenesis.
PMID	PMID:30400182	16	62	9606	OAS3,ISG20,STAT2,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,PARP14	OAS3,ISG20,STAT2,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,PARP14	3.84e-26	1.51e-20	(2018) Transcriptomics Reveal Antiviral Gene Induction in the Egyptian Rousette Bat Is Antagonized In Vitro by Marburg Virus Infection.
PMID	PMID:34552595	16	65	9606	OAS3,BST2,PML,STAT2,MX2,OAS2,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,MX1,OAS1,IFI35,IFITM2	OAS3,BST2,PML,STAT2,MX2,OAS2,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,MX1,OAS1,IFI35,IFITM2	7.45e-26	2.67e-20	(2021) Tissue-Resident-Memory CD8(+) T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes.
PMID	PMID:28106799	14	32	9606	OAS3,SAMHD1,ISG20,STAT2,MX2,OAS2,CTSS,IFIT1,IFIT3,ISG15,DDX58,IRF9,MX1,OAS1	OAS3,SAMHD1,ISG20,STAT2,MX2,OAS2,CTSS,IFIT1,IFIT3,ISG15,DDX58,IRF9,MX1,OAS1	1.21e-25	3.97e-20	(2017) RNA Editing, ADAR1, and the Innate Immune Response.
PMID	PMID:35281454	14	34	9606	DTX3L,STAT2,MX2,PARP9,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,IRF9,MX1,OAS1,PARP14	DTX3L,STAT2,MX2,PARP9,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,IRF9,MX1,OAS1,PARP14	2.42e-25	7.33e-20	(2022) Streptococcus pneumoniae and Influenza A Virus Co-Infection Induces Altered Polyubiquitination in A549 Cells.
PMID	PMID:33810083	18	127	9606	OAS3,BST2,ATP4A,ISG20,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,ATP4A,ISG20,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1,IFITM2	3.53e-25	9.95e-20	(2021) Mammalian and Avian Host Cell Influenza A Restriction Factors.
PMID	PMID:34292740	16	76	9606	OAS3,CMPK2,ISG20,STAT2,MX2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,PARP14	OAS3,CMPK2,ISG20,STAT2,MX2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,PARP14	6.84e-25	1.8e-19	(2021) DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients.
PMID	PMID:29416731	14	42	9606	NMI,PML,STAT2,MX2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	NMI,PML,STAT2,MX2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	2.86e-24	7.05e-19	(2018) Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.
PMID	PMID:27479908	16	92	9606	OAS3,CMPK2,STAT2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,HLA-A,MX1,OAS1,IFI35,IFITM2	OAS3,CMPK2,STAT2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,HLA-A,MX1,OAS1,IFI35,IFITM2	1.07e-23	2.48e-18	(2016) Tensor decomposition for multiple-tissue gene expression experiments.
PMID	PMID:25128762	17	135	9606	OAS3,BST2,SAMHD1,HERC6,STAT2,OAS2,SP100,IFIT5,IFIT1,IFIT3,PSMB9,ISG15,DDX58,TRIM22,MX1,OAS1,IFI35	OAS3,BST2,SAMHD1,HERC6,STAT2,OAS2,SP100,IFIT5,IFIT1,IFIT3,PSMB9,ISG15,DDX58,TRIM22,MX1,OAS1,IFI35	5.57e-23	1.22e-17	(2014) Virus-host mucosal interactions during early SIV rectal transmission.
PMID	PMID:32164778	13	37	9606	OAS3,BST2,ISG20,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1,IFI35	OAS3,BST2,ISG20,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1,IFI35	7.86e-23	1.63e-17	(2020) Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
PMID	PMID:29892288	14	56	9606	OAS3,BST2,DTX3L,STAT2,OAS2,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,IRF9,MX1,OAS1,IFI35	OAS3,BST2,DTX3L,STAT2,OAS2,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,IRF9,MX1,OAS1,IFI35	9.25e-23	1.82e-17	(2018) A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
PMID	PMID:27533247	14	57	9606	CMPK2,STAT2,PLAUR,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,SAMD9,IRF9,MX1,HELZ2	CMPK2,STAT2,PLAUR,OAS2,SP100,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,SAMD9,IRF9,MX1,HELZ2	1.15e-22	2.16e-17	(2016) Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
PMID	PMID:34880855	12	24	9606	OAS3,BST2,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,IRF9,MX1,OAS1	OAS3,BST2,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,IRF9,MX1,OAS1	1.24e-22	2.22e-17	(2021) Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
PMID	PMID:34990653	15	82	9606	OAS3,APOL2,BST2,STAT2,PLAUR,OAS2,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,OAS1,IFITM2	OAS3,APOL2,BST2,STAT2,PLAUR,OAS2,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,OAS1,IFITM2	1.54e-22	2.65e-17	(2022) Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.
PMID	PMID:26198243	14	60	9606	BST2,PML,ISG20,STAT2,MX2,IFIT5,IFIT1,IFIT3,IFIT2,DDX58,IRF9,MX1,IFI35,IFITM2	BST2,PML,ISG20,STAT2,MX2,IFIT5,IFIT1,IFIT3,IFIT2,DDX58,IRF9,MX1,IFI35,IFITM2	2.16e-22	3.56e-17	(2015) Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses.
PMID	PMID:25754082	12	26	9606	OAS3,DTX3L,STAT2,OAS2,PARP9,IFIT5,IFIT3,DDX58,TRIM22,OAS1,IFI35,PARP14	OAS3,DTX3L,STAT2,OAS2,PARP9,IFIT5,IFIT3,DDX58,TRIM22,OAS1,IFI35,PARP14	2.67e-22	4.19e-17	(2015) Gene networks specific for innate immunity define post-traumatic stress disorder.
PMID	PMID:22483866	14	61	9606	OAS3,BST2,ISG20,STAT2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,OAS1	OAS3,BST2,ISG20,STAT2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,OAS1	2.66e-22	4.19e-17	(2012) The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells.
PMID	PMID:29880853	14	64	9606	ISG20,STAT2,MX2,PARP9,IFIT1,IFIT3,PSMB9,ISG15,DDX58,IRF9,MX1,OAS1,IFI35,PARP14	ISG20,STAT2,MX2,PARP9,IFIT1,IFIT3,PSMB9,ISG15,DDX58,IRF9,MX1,OAS1,IFI35,PARP14	4.82e-22	7.04e-17	(2018) Immunoprofiles of human Sertoli cells infected with Zika virus reveals unique insights into host-pathogen crosstalk.
PMID	PMID:28805681	15	92	9606	OAS3,GMPR,ISG20,MX2,OAS2,PARP9,IFIT1,ISG15,DDX58,SAMD9,TRIM22,MX1,OAS1,HELZ2,PARP14	OAS3,GMPR,ISG20,MX2,OAS2,PARP9,IFIT1,ISG15,DDX58,SAMD9,TRIM22,MX1,OAS1,HELZ2,PARP14	7.38e-22	1.04e-16	(2017) Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
PMID	PMID:24065129	12	29	9606	OAS3,BST2,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,IRF9,MX1,OAS1	OAS3,BST2,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,IRF9,MX1,OAS1	7.75e-22	1.05e-16	(2013) IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
PMID	PMID:28806913	12	31	9606	OAS3,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFITM2	OAS3,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFITM2	1.5e-21	1.97e-16	(2017) Proteomics informed by transcriptomics for characterising differential cellular susceptibility to Nelson Bay orthoreovirus infection.
PMID	PMID:23369858	13	50	9606	OAS3,BST2,ISG20,STAT2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,OAS1	OAS3,BST2,ISG20,STAT2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,OAS1	2.26e-21	2.87e-16	(2013) What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?
PMID	PMID:35235083	11	20	9606	OAS3,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS3,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	3.61e-21	4.45e-16	(2022) Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
PMID	PMID:32899429	16	137	9606	OAS3,BST2,CMPK2,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	OAS3,BST2,CMPK2,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	3.68e-21	4.45e-16	(2020) LncRNAs in the Type I Interferon Antiviral Response.
PMID	PMID:34372499	12	35	9606	PML,ISG20,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1	PML,ISG20,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1,OAS1	5.06e-21	5.87e-16	(2021) Transcriptome and Proteomic Analysis Reveals Up-Regulation of Innate Immunity-Related Genes Expression in Caprine Herpesvirus 1 Infected Madin Darby Bovine Kidney Cells.
PMID	PMID:28959263	13	54	9606	BST2,SAMHD1,STAT2,MX2,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,HLA-A,IRF9,MX1,TAPBP	BST2,SAMHD1,STAT2,MX2,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,HLA-A,IRF9,MX1,TAPBP	5.42e-21	6.11e-16	(2017) Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression.
PMID	PMID:34785679	13	55	9606	BST2,CMPK2,ATP4A,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1	BST2,CMPK2,ATP4A,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1	6.69e-21	7.33e-16	(2021) SARS-CoV-2 infection and replication in human gastric organoids.
PMID	PMID:22703193	14	79	9606	BST2,SAMHD1,ISG20,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFI35,IFITM2	BST2,SAMHD1,ISG20,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFI35,IFITM2	6.77e-21	7.33e-16	(2012) Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjoegrens syndrome.
PMID	PMID:33922087	14	80	9606	OAS3,BST2,HERC6,STAT2,MX2,OAS2,IFIT1,IFIT3,ISG15,DDX58,IRF9,MX1,OAS1,IFI35	OAS3,BST2,HERC6,STAT2,MX2,OAS2,IFIT1,IFIT3,ISG15,DDX58,IRF9,MX1,OAS1,IFI35	7.94e-21	8.24e-16	(2021) Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes.
PMID	PMID:35086375	12	37	9606	OAS3,BST2,HERC6,ISG20,MX2,OAS2,IFIT1,ISG15,TRIM22,MX1,OAS1,IFI35	OAS3,BST2,HERC6,ISG20,MX2,OAS2,IFIT1,ISG15,TRIM22,MX1,OAS1,IFI35	8.89e-21	9e-16	(2022) Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis.
PMID	PMID:27791205	13	57	9606	BST2,STAT2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,SAMD9,IRF9,MX1,OAS1,PARP14	BST2,STAT2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,SAMD9,IRF9,MX1,OAS1,PARP14	1.01e-20	9.95e-16	(2016) Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.
PMID	PMID:23847613	13	58	9606	BST2,SAMHD1,ISG20,STAT2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,IRF9,MX1,OAS1,IFI35	BST2,SAMHD1,ISG20,STAT2,OAS2,IFIT1,IFIT3,IFIT2,DDX58,IRF9,MX1,OAS1,IFI35	1.23e-20	1.19e-15	(2013) The Interferon-Signature of Sjoegrens Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.
PMID	PMID:26859759	11	24	9606	ISG20,STAT2,MX2,OAS2,IFIT1,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	ISG20,STAT2,MX2,OAS2,IFIT1,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	1.76e-20	1.65e-15	(2016) Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling.
PMID	PMID:31015447	13	60	9606	OAS3,BST2,OAS2,SP100,IFIT3,PSMB9,ISG15,TRIM22,HLA-A,IRF9,MX1,IFI35,TAPBP	OAS3,BST2,OAS2,SP100,IFIT3,PSMB9,ISG15,TRIM22,HLA-A,IRF9,MX1,IFI35,TAPBP	1.82e-20	1.67e-15	(2019) Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions.
PMID	PMID:27434537	13	64	9606	OAS3,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,USP41	OAS3,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,USP41	3.85e-20	3.45e-15	(2016) Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling.
PMID	PMID:30621583	14	92	9606	ISG20,STAT2,MX2,PLAUR,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFI35	ISG20,STAT2,MX2,PLAUR,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFI35	4.7e-20	4.12e-15	(2019) Bacterial and viral pathogen-associated molecular patterns induce divergent early transcriptomic landscapes in a bovine macrophage cell line.
PMID	PMID:33560295	13	68	9606	OAS3,BST2,HERC6,OAS2,IFIT5,IFIT1,IFIT2,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	OAS3,BST2,HERC6,OAS2,IFIT5,IFIT1,IFIT2,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	7.79e-20	6.68e-15	(2021) An OMICs based meta-analysis to support infection state stratification.
PMID	PMID:34937051	12	46	9606	BST2,CMPK2,MX2,OAS2,PARP9,IFIT3,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	BST2,CMPK2,MX2,OAS2,PARP9,IFIT3,ISG15,SAMD9,TRIM22,MX1,OAS1,IFI35	8.43e-20	7.08e-15	(2022) Local and systemic responses to SARS-CoV-2 infection in children and adults.
PMID	PMID:34857786	14	99	9606	BST2,CMPK2,SAMHD1,DTX3L,MX2,OAS2,SP100,PARP9,IFIT1,IFIT3,PSMB9,ISG15,HLA-A,MX1	BST2,CMPK2,SAMHD1,DTX3L,MX2,OAS2,SP100,PARP9,IFIT1,IFIT3,PSMB9,ISG15,HLA-A,MX1	1.2e-19	9.88e-15	(2021) Integrative epigenomics in Sjoegrens syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.
PMID	PMID:34944900	12	48	9606	OAS3,BST2,HERC6,OAS2,PARP9,IFIT1,IFIT3,ISG15,SAMD9,IRF9,OAS1,IFI35	OAS3,BST2,HERC6,OAS2,PARP9,IFIT1,IFIT3,ISG15,SAMD9,IRF9,OAS1,IFI35	1.32e-19	1.06e-14	(2021) Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer.
PMID	PMID:35171909	13	72	9606	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,CTSS,IFIT2,ISG15,DDX58,TRIM22,LGALS9,MX1	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,CTSS,IFIT2,ISG15,DDX58,TRIM22,LGALS9,MX1	1.52e-19	1.2e-14	(2022) Zika virus disrupts gene expression in human myoblasts and myotubes: Relationship with susceptibility to infection.
PMID	PMID:33142113	13	72	9606	OAS3,BST2,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	OAS3,BST2,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	1.52e-19	1.2e-14	(2020) Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
PMID	PMID:20709292	14	101	9606	OAS3,CMPK2,STAT2,MX2,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,LGALS9,MX1,PARP14,RNF213	OAS3,CMPK2,STAT2,MX2,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,LGALS9,MX1,PARP14,RNF213	1.55e-19	1.2e-14	(2010) Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.
PMID	PMID:31487323	14	102	9606	BST2,HERC6,MX2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1,OAS1,RNF213,IFITM2	BST2,HERC6,MX2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1,OAS1,RNF213,IFITM2	1.76e-19	1.31e-14	(2019) Differential gene expression in bovine endometrial epithelial cells after challenge with LPS; specific implications for genes involved in embryo maternal interactions.
PMID	PMID:33405206	12	50	9606	ISG20,STAT2,PARP9,IFIT1,IFIT3,PSMB9,ISG15,IRF9,MX1,OAS1,IFI35,PARP14	ISG20,STAT2,PARP9,IFIT1,IFIT3,PSMB9,ISG15,IRF9,MX1,OAS1,IFI35,PARP14	2.03e-19	1.48e-14	(2021) Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeutic targets.
PMID	PMID:34599159	14	105	9606	DTX3L,OAS2,PARP9,ARHGAP18,IFIT5,IFIT1,IFIT3,IFIT2,DDX58,SAMD9,HLA-A,OAS1,IFI35,PARP14	DTX3L,OAS2,PARP9,ARHGAP18,IFIT5,IFIT1,IFIT3,IFIT2,DDX58,SAMD9,HLA-A,OAS1,IFI35,PARP14	2.56e-19	1.79e-14	(2021) Spatiotemporal proteomic profiling of the pro-inflammatory response to lipopolysaccharide in the THP-1 human leukaemia cell line.
PMID	PMID:29264452	12	51	9606	OAS3,APOL2,SAMHD1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TYMP,HLA-A,MX1,TAPBP	OAS3,APOL2,SAMHD1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TYMP,HLA-A,MX1,TAPBP	2.5e-19	1.79e-14	(2017) Coxsackievirus-Induced Proteomic Alterations in Primary Human Islets Provide Insights for the Etiology of Diabetes.
PMID	PMID:23299892	12	51	9606	OAS3,HERC6,STAT2,OAS2,IFIT3,IFIT2,ISG15,TRIM22,IRF9,MX1,OAS1,HELZ2	OAS3,HERC6,STAT2,OAS2,IFIT3,IFIT2,ISG15,TRIM22,IRF9,MX1,OAS1,HELZ2	2.5e-19	1.79e-14	(2013) Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans.
PMID	PMID:23781071	12	51	9606	SAMHD1,ISG20,STAT2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	SAMHD1,ISG20,STAT2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	2.5e-19	1.79e-14	(2013) A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response.
PMID	PMID:34205050	12	52	9606	BST2,STAT2,MX2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,IFI35	BST2,STAT2,MX2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,IFI35	3.07e-19	2.05e-14	(2021) Comparative Analysis of Public RNA-Sequencing Data from Human Intestinal Enteroid (HIEs) Infected with Enteric RNA Viruses Identifies Universal and Virus-Specific Epithelial Responses.
PMID	PMID:34992733	11	33	9606	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,ISG15,HLA-A,IRF9,MX1,IFI35	OAS3,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,ISG15,HLA-A,IRF9,MX1,IFI35	3.18e-19	2.09e-14	(2022) Global proteomics of fibroblast cells treated with bacterial cyclic dinucleotides, c-di-GMP and c-di-AMP.
PMID	PMID:31058188	11	33	9606	HERC6,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,IFI35,PARP14	HERC6,OAS2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,IFI35,PARP14	3.18e-19	2.09e-14	(2019) What Changed on the Folliculogenesis in the Process of Mouse Ovarian Aging?
PMID	PMID:34818375	10	19	9606	OAS3,MX2,OAS2,IFIT3,ISG15,DDX58,MX1,OAS1,IFI35,IFITM2	OAS3,MX2,OAS2,IFIT3,ISG15,DDX58,MX1,OAS1,IFI35,IFITM2	3.57e-19	2.27e-14	(2021) Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis.
PMID	PMID:24678238	12	53	9606	OAS3,BST2,OAS2,IFIT5,IFIT1,IFIT3,PSMB9,ISG15,TRIM22,MX1,OAS1,IFI35	OAS3,BST2,OAS2,IFIT5,IFIT1,IFIT3,PSMB9,ISG15,TRIM22,MX1,OAS1,IFI35	3.75e-19	2.35e-14	(2012) High-Dimensional Longitudinal Genomic Data: An analysis used for monitoring viral infections.
PMID	PMID:30496325	11	34	9606	UBA7,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,MX1	UBA7,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,MX1	4.19e-19	2.59e-14	(2018) Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity.
PMID	PMID:26667656	13	80	9606	BST2,CMPK2,ISG20,STAT2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,IFI35,IFITM2	BST2,CMPK2,ISG20,STAT2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,IFI35,IFITM2	5.26e-19	3.19e-14	(2016) lncRNAs regulate the innate immune response to viral infection.
PMID	PMID:22531325	13	81	9606	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,OAS2,ISG15,TRIM22,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,OAS2,ISG15,TRIM22,IRF9,MX1,OAS1,IFITM2	6.09e-19	3.64e-14	(2012) Interferon-inducible effector mechanisms in cell-autonomous immunity.
PMID	PMID:30513968	11	36	9606	BST2,PML,ISG20,STAT2,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1	BST2,PML,ISG20,STAT2,IFIT3,IFIT2,ISG15,DDX58,TRIM22,IRF9,MX1	7.17e-19	4.22e-14	(2018) Rhabdoviruses, Antiviral Defense, and SUMO Pathway.
PMID	PMID:26695443	11	36	9606	BST2,STAT2,OAS2,PARP9,IFIT1,IFIT3,ISG15,SAMD9,IRF9,MX1,OAS1	BST2,STAT2,OAS2,PARP9,IFIT1,IFIT3,ISG15,SAMD9,IRF9,MX1,OAS1	7.17e-19	4.22e-14	(2016) Activation of IFNSTAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
PMID	PMID:18648529	13	83	9606	OAS3,HERC6,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	OAS3,HERC6,STAT2,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	8.12e-19	4.64e-14	(2008) Type I interferon: potential therapeutic target for psoriasis?
PMID	PMID:25377889	11	37	9606	HERC6,ISG20,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35	HERC6,ISG20,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35	9.28e-19	5.23e-14	(2014) Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection.
PMID	PMID:35131898	11	38	9606	ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFI35	ISG20,STAT2,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFI35	1.19e-18	6.55e-14	(2022) Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
PMID	PMID:33450175	12	59	9606	OAS3,BST2,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM2	OAS3,BST2,SAMHD1,MX2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,IFITM2	1.18e-18	6.55e-14	(2021) Evolutionary conflicts and adverse effects of antiviral factors.
PMID	PMID:33147460	13	86	9606	OAS3,BST2,ISG20,STAT2,UBA7,MX2,OAS2,IFIT1,IFIT2,DDX58,IRF9,MX1,RNF213	OAS3,BST2,ISG20,STAT2,UBA7,MX2,OAS2,IFIT1,IFIT2,DDX58,IRF9,MX1,RNF213	1.24e-18	6.68e-14	(2020) Interferon Regulatory Factors IRF1 and IRF7 Directly Regulate Gene Expression in Bats in Response to Viral Infection.
PMID	PMID:28701698	14	119	9606	OAS3,BST2,SAMHD1,ISG20,MX2,OAS2,IFIT5,IFIT3,IFIT2,ISG15,TRIM22,MX1,OAS1,IFI35	OAS3,BST2,SAMHD1,ISG20,MX2,OAS2,IFIT5,IFIT3,IFIT2,ISG15,TRIM22,MX1,OAS1,IFI35	1.29e-18	6.86e-14	(2017) Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin.
PMID	PMID:30501627	12	60	9606	OAS3,BST2,SAMHD1,DTX3L,STAT2,OAS2,ISG15,HLA-A,IRF9,OAS1,TAPBP,HELZ2	OAS3,BST2,SAMHD1,DTX3L,STAT2,OAS2,ISG15,HLA-A,IRF9,OAS1,TAPBP,HELZ2	1.41e-18	7.42e-14	(2018) Profiling the proteomic inflammatory state of human astrocytes using DIA mass spectrometry.
PMID	PMID:31156620	11	39	9606	OAS3,BST2,HERC6,STAT2,OAS2,IFIT1,ISG15,DDX58,IRF9,MX1,OAS1	OAS3,BST2,HERC6,STAT2,OAS2,IFIT1,ISG15,DDX58,IRF9,MX1,OAS1	1.53e-18	7.93e-14	(2019) IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response.
PMID	PMID:25902143	11	39	9606	OAS3,CMPK2,SAMHD1,HERC6,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1	OAS3,CMPK2,SAMHD1,HERC6,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1	1.53e-18	7.93e-14	(2015) Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
PMID	PMID:31611566	11	40	9606	ISG20,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	ISG20,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	1.94e-18	9.83e-14	(2019) Experimental challenge with bovine respiratory syncytial virus in dairy calves: bronchial lymph node transcriptome response.
PMID	PMID:28786993	10	24	9606	OAS3,ISG20,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,OAS1,IFI35	OAS3,ISG20,MX2,OAS2,SP100,IFIT1,IFIT3,IFIT2,OAS1,IFI35	2.31e-18	1.15e-13	(2017) A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study.
PMID	PMID:34733317	13	91	9606	CMPK2,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT3,ISG15,DDX58,IRF9,MX1,IFI35,PARP14	CMPK2,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT3,ISG15,DDX58,IRF9,MX1,IFI35,PARP14	2.42e-18	1.19e-13	(2021) Integrated Network Analysis to Identify Key Modules and Potential Hub Genes Involved in Bovine Respiratory Disease: A Systems Biology Approach.
PMID	PMID:31861316	11	41	9606	BST2,DTX3L,MX2,PARP9,IFIT1,IFIT3,ISG15,DDX58,SAMD9,IRF9,MX1	BST2,DTX3L,MX2,PARP9,IFIT1,IFIT3,ISG15,DDX58,SAMD9,IRF9,MX1	2.46e-18	1.2e-13	(2019) Bovine Viral Diarrhoea Virus Infection Disrupts Uterine Interferon Stimulated Gene Regulatory Pathways During Pregnancy Recognition in Cows.
PMID	PMID:17488182	12	64	9606	OAS3,STAT2,MX2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,IRF9,MX1,OAS1	OAS3,STAT2,MX2,PARP9,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,IRF9,MX1,OAS1	2.82e-18	1.36e-13	(2007) Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
PMID	PMID:34559160	11	42	9606	OAS3,HERC6,ISG20,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,HERC6,ISG20,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	3.1e-18	1.47e-13	(2021) CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction.
PMID	PMID:31641281	11	42	9606	OAS3,SAMHD1,HERC6,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,SAMHD1,HERC6,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	3.1e-18	1.47e-13	(2020) A clinical score to guide in decision making for monogenic type I IFNopathies.
PMID	PMID:32114504	10	25	9606	OAS3,BST2,STAT2,OAS2,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	OAS3,BST2,STAT2,OAS2,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	3.23e-18	1.47e-13	(2020) Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus.
PMID	PMID:32117146	10	25	9606	OAS3,NMI,STAT2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,IRF9,OAS1	OAS3,NMI,STAT2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,IRF9,OAS1	3.23e-18	1.47e-13	(2020) One Step Ahead: Herpesviruses Light the Way to Understanding Interferon-Stimulated Genes (ISGs).
PMID	PMID:32325933	11	42	9606	BST2,ISG20,MX2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	BST2,ISG20,MX2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	3.1e-18	1.47e-13	(2020) RNAseq Reveals the Contribution of Interferon Stimulated Genes to the Increased Host Defense and Decreased PPR Viral Replication in Cattle.
PMID	PMID:30915053	11	42	9606	BST2,SAMHD1,ISG20,MX2,SP100,ISG15,DDX58,LGALS9,IRF9,MX1,OAS1	BST2,SAMHD1,ISG20,MX2,SP100,ISG15,DDX58,LGALS9,IRF9,MX1,OAS1	3.1e-18	1.47e-13	(2019) Comparative Description of the Expression Profile of Interferon-Stimulated Genes in Multiple Cell Lineages Targeted by HIV-1 Infection.
PMID	PMID:31949544	10	25	9606	BST2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,MX1,OAS1	BST2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,SAMD9,MX1,OAS1	3.23e-18	1.47e-13	(2019) Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
PMID	PMID:29947965	10	25	9606	OAS3,BST2,HERC6,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFI35	OAS3,BST2,HERC6,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFI35	3.23e-18	1.47e-13	(2018) Of mice and men: the host response to influenza virus infection.
PMID	PMID:31364746	10	26	9606	OAS3,BST2,HERC6,MX2,OAS2,IFIT1,ISG15,DDX58,SAMD9,OAS1	OAS3,BST2,HERC6,MX2,OAS2,IFIT1,ISG15,DDX58,SAMD9,OAS1	4.46e-18	1.93e-13	(2019) Characteristic genes in THP-1 derived macrophages infected with Mycobacterium tuberculosis H37Rv strain identified by integrating bioinformatics methods.
PMID	PMID:22906315	11	44	9606	OAS3,STAT2,MX2,IFIT5,IFIT1,IFIT3,IFIT2,DDX58,IRF9,MX1,OAS1	OAS3,STAT2,MX2,IFIT5,IFIT1,IFIT3,IFIT2,DDX58,IRF9,MX1,OAS1	4.84e-18	2.08e-13	(2012) Chemoattraction of macrophages by secretory molecules derived from cells expressing the signal peptide of eosinophil cationic protein.
PMID	PMID:22328912	11	44	9606	BST2,ISG20,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFITM2	BST2,ISG20,IFIT1,IFIT3,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1,IFITM2	4.84e-18	2.08e-13	(2011) Interferon-stimulated genes and their antiviral effector functions.
PMID	PMID:31877408	11	45	9606	OAS3,BST2,STAT2,OAS2,PSMB9,ISG15,DDX58,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,STAT2,OAS2,PSMB9,ISG15,DDX58,IRF9,MX1,OAS1,IFITM2	6.01e-18	2.52e-13	(2020) Identification of Regulatory Modules That Stratify Lupus Disease Mechanism through Integrating Multi-Omics Data.
PMID	PMID:29441069	11	46	9606	OAS3,APOL2,BST2,STAT2,OAS2,IFIT5,IFIT1,DDX58,HLA-A,IRF9,OAS1	OAS3,APOL2,BST2,STAT2,OAS2,IFIT5,IFIT1,DDX58,HLA-A,IRF9,OAS1	7.43e-18	3.09e-13	(2018) Interleukin-6 and Interferon-alpha Signaling via JAK1-STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States.
PMID	PMID:27230536	10	28	9606	ISG20,STAT2,MX2,IFIT1,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	ISG20,STAT2,MX2,IFIT1,IFIT2,ISG15,DDX58,IRF9,MX1,OAS1	8.25e-18	3.39e-13	(2016) Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies.
PMID	PMID:28432378	11	47	9606	OAS3,BST2,STAT2,MX2,OAS2,ISG15,TRIM22,IRF9,MX1,OAS1,IFITM2	OAS3,BST2,STAT2,MX2,OAS2,ISG15,TRIM22,IRF9,MX1,OAS1,IFITM2	9.15e-18	3.72e-13	(2017) Advances in anti-viral immune defence: revealing the importance of the IFN JAKSTAT pathway.
PMID	PMID:23624185	11	47	9606	STAT2,UBA7,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,MX1,TAPBP	STAT2,UBA7,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,MX1,TAPBP	9.15e-18	3.72e-13	(2013) Defense genes missing from the flight division.
PMID	PMID:33276587	11	48	9606	BST2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	BST2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	1.12e-17	4.47e-13	(2020) Host Cell Restriction Factors of Paramyxoviruses and Pneumoviruses.
PMID	PMID:34795220	11	49	9606	OAS3,STAT2,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,IRF9,OAS1	OAS3,STAT2,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,IRF9,OAS1	1.37e-17	5.41e-13	(2021) Epromoters function as a hub to recruit key transcription factors required for the inflammatory response.
RCTM	HSA-913531	24	196	9606	OAS3,BST2,SAMHD1,PML,ISG20,STAT2,UBA7,MX2,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,IRF9,MX1,OAS1,IFI35,USP41,IFITM2	OAS3,BST2,SAMHD1,PML,ISG20,STAT2,UBA7,MX2,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,HLA-A,IRF9,MX1,OAS1,IFI35,USP41,IFITM2	2.35e-32	5.1e-29	Interferon Signaling
RCTM	HSA-909733	18	69	9606	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	OAS3,BST2,SAMHD1,ISG20,STAT2,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,HLA-A,IRF9,MX1,OAS1,IFI35,IFITM2	1.82e-29	1.97e-26	Interferon alpha/beta signaling
RCTM	HSA-1280215	26	681	9606	OAS3,BST2,SAMHD1,PML,ISG20,STAT2,UBA7,MX2,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,USP41,IFITM2	OAS3,BST2,SAMHD1,PML,ISG20,STAT2,UBA7,MX2,OAS2,SP100,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,USP41,IFITM2	8.07e-23	5.84e-20	Cytokine Signaling in Immune system
RCTM	HSA-168256	32	1956	9606	OAS3,BST2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,PLAUR,OAS2,SP100,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,RNF213,IFITM2	OAS3,BST2,SAMHD1,HERC6,PML,DTX3L,ISG20,STAT2,UBA7,MX2,PLAUR,OAS2,SP100,CTSS,IFIT5,IFIT1,IFIT3,IFIT2,PSMB9,ISG15,DDX58,TRIM22,LGALS9,HLA-A,IRF9,MX1,OAS1,IFI35,TAPBP,USP41,RNF213,IFITM2	9.44e-18	5.13e-15	Immune System
RCTM	HSA-1169410	10	81	9606	OAS3,UBA7,MX2,OAS2,IFIT1,ISG15,DDX58,MX1,OAS1,USP41	OAS3,UBA7,MX2,OAS2,IFIT1,ISG15,DDX58,MX1,OAS1,USP41	9.99e-14	4.34e-11	Antiviral mechanism by IFN-stimulated genes
RCTM	HSA-877300	8	88	9606	OAS3,PML,OAS2,SP100,TRIM22,HLA-A,IRF9,OAS1	OAS3,PML,OAS2,SP100,TRIM22,HLA-A,IRF9,OAS1	3.31e-10	1.2e-07	Interferon gamma signaling
RCTM	HSA-1169408	7	73	9606	UBA7,MX2,IFIT1,ISG15,DDX58,MX1,USP41	UBA7,MX2,IFIT1,ISG15,DDX58,MX1,USP41	3.21e-09	9.97e-07	ISG15 antiviral mechanism
RCTM	HSA-8983711	4	9	9606	OAS3,OAS2,DDX58,OAS1	OAS3,OAS2,DDX58,OAS1	4.48e-08	1.22e-05	OAS antiviral response
RCTM	HSA-983169	8	366	9606	HERC6,DTX3L,UBA7,CTSS,PSMB9,HLA-A,TAPBP,RNF213	HERC6,DTX3L,UBA7,CTSS,PSMB9,HLA-A,TAPBP,RNF213	1.18e-05	0.0029	Class I MHC mediated antigen processing & presentation
RCTM	HSA-936440	3	33	9606	UBA7,ISG15,DDX58	UBA7,ISG15,DDX58	0.00015	0.0337	Negative regulators of DDX58/IFIH1 signaling
RCTM	HSA-1236975	4	97	9606	CTSS,PSMB9,HLA-A,TAPBP	CTSS,PSMB9,HLA-A,TAPBP	0.00021	0.0418	Antigen processing-Cross presentation
WikiPathways	WP4197	7	23	9606	STAT2,IFIT1,IFIT3,IRF9,MX1,OAS1,IFI35	STAT2,IFIT1,IFIT3,IRF9,MX1,OAS1,IFI35	2.3e-12	1.56e-09	Immune response to tuberculosis
WikiPathways	WP4868	6	31	9606	OAS3,STAT2,OAS2,DDX58,IRF9,OAS1	OAS3,STAT2,OAS2,DDX58,IRF9,OAS1	9.94e-10	3.37e-07	Type I interferon induction and signaling during SARS-CoV-2 infection
WikiPathways	WP4880	6	33	9606	OAS3,STAT2,OAS2,DDX58,IRF9,OAS1	OAS3,STAT2,OAS2,DDX58,IRF9,OAS1	1.39e-09	3.37e-07	Host-pathogen interaction of human coronaviruses - interferon induction
WikiPathways	WP619	6	37	9606	STAT2,IFIT2,PSMB9,ISG15,IRF9,OAS1	STAT2,IFIT2,PSMB9,ISG15,IRF9,OAS1	2.57e-09	4.36e-07	Type II interferon signaling (IFNG)
WikiPathways	WP4705	3	16	9606	SAMHD1,DDX58,OAS1	SAMHD1,DDX58,OAS1	2.18e-05	0.003	Pathways of nucleic acid metabolism and innate immune sensing
WikiPathways	WP5039	4	66	9606	STAT2,IFIT2,DDX58,MX1	STAT2,IFIT2,DDX58,MX1	5.09e-05	0.0057	SARS-CoV-2 innate immunity evasion and cell-specific immune response
WikiPathways	WP4912	3	31	9606	STAT2,DDX58,IRF9	STAT2,DDX58,IRF9	0.00013	0.0126	SARS coronavirus and innate immunity
WikiPathways	WP2113	2	10	9606	STAT2,IRF9	STAT2,IRF9	0.00054	0.0455	Type III interferon signaling
NetworkNeighborAL	CL:19379	23	83	9606	OAS3,SAMHD1,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1,IFI35,USP41,PARP14,RNF213,IFITM2	OAS3,SAMHD1,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1,IFI35,USP41,PARP14,RNF213,IFITM2	2.51e-38	1.14e-34	Mixed, incl. interferon alpha/beta signaling, and negative regulation of type i interferon production
NetworkNeighborAL	CL:19382	22	67	9606	OAS3,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1,IFI35,USP41,PARP14,RNF213,IFITM2	OAS3,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,TRIM22,MX1,OAS1,IFI35,USP41,PARP14,RNF213,IFITM2	5.16e-38	1.17e-34	Mixed, incl. interferon alpha/beta signaling, and negative regulators of ddx58/ifih1 signaling
NetworkNeighborAL	CL:19389	19	42	9606	OAS3,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1,IFI35,PARP14,RNF213,IFITM2	OAS3,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1,IFI35,PARP14,RNF213,IFITM2	5.88e-35	6.68e-32	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19385	20	61	9606	OAS3,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35,PARP14,RNF213,IFITM2	OAS3,HERC6,DTX3L,ISG20,UBA7,MX2,OAS2,PARP9,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,IFI35,PARP14,RNF213,IFITM2	1.74e-34	1.59e-31	Interferon alpha/beta signaling, and Negative regulators of DDX58/IFIH1 signaling
NetworkNeighborAL	CL:19391	15	36	9606	OAS3,HERC6,ISG20,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1,IFI35,IFITM2	OAS3,HERC6,ISG20,UBA7,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1,IFI35,IFITM2	3.49e-27	2.64e-24	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19394	12	21	9606	OAS3,ISG20,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,MX1,OAS1,IFI35,IFITM2	OAS3,ISG20,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,MX1,OAS1,IFI35,IFITM2	3.54e-23	2.3e-20	Interferon alpha/beta signaling
NetworkNeighborAL	CL:19397	11	16	9606	OAS3,ISG20,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,MX1,OAS1,IFI35	OAS3,ISG20,MX2,OAS2,IFIT5,IFIT1,IFIT3,IFIT2,MX1,OAS1,IFI35	5.6e-22	3.18e-19	Microphthalmia with limb anomalies, and Interferon alpha/beta signaling
NetworkNeighborAL	CL:19399	8	11	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,OAS1,IFI35	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,OAS1,IFI35	2.24e-16	1.13e-13	Mixed, incl. 2-5-oligoadenylate synthetase activity, and nephropathia epidemica
NetworkNeighborAL	CL:19402	4	5	9606	OAS2,IFIT1,IFIT3,IFIT2	OAS2,IFIT1,IFIT3,IFIT2	7.97e-09	3.62e-06	Mixed, incl. 4fe-4s single cluster domain, and interferon-induced protein with tetratricopeptide repeats 3
NetworkNeighborAL	CL:19463	4	5	9606	DTX3L,PARP9,PARP14,RNF213	DTX3L,PARP9,PARP14,RNF213	7.97e-09	3.62e-06	Appr-1-p processing enzyme, and DTX3L, RING-HC finger
NetworkNeighborAL	CL:19437	3	13	9606	HERC6,UBA7,ISG15	HERC6,UBA7,ISG15	1.27e-05	0.0048	Mixed, incl. isg15-protein conjugation, and interferon-induced protein 44 family
